Article Details

In an $11B deal, Merck will acquire Acceleron | 2021-09-30 | BioWorld

Retrieved on: 2021-09-30 18:56:15

Tags for this article:

Click the tags to see associated articles and topics

In an $11B deal, Merck will acquire Acceleron | 2021-09-30 | BioWorld. View article details on hiswai:

Excerpt

Roche-Regeneron cocktail reduces viral load in hospitalized COVID-19 patients. New data on the COVID-19 antibody therapy Ronapreve (casirivimab + imdevimab), ...

Article found on: www.bioworld.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up